Heart Test Laboratories, Inc. Stock
Equities
HSCS
US42254E3027
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.59 USD | -4.93% | -28.70% | -67.02% |
Sales 2024 * | 59.3K 80.96K | Sales 2025 * | 1.9M 2.59M | Capitalization | 3.86M 5.26M |
---|---|---|---|---|---|
Net income 2024 * | -6M -8.19M | Net income 2025 * | -9M -12.29M | EV / Sales 2024 * | 65 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.03 x |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
-0.56
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.99% |
1 day | -4.93% | ||
1 week | -28.70% | ||
Current month | -38.96% | ||
1 month | -43.54% | ||
3 months | -52.96% | ||
6 months | -71.24% | ||
Current year | -67.02% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Danielle Watson
DFI | Director of Finance/CFO | 42 | 21-10-31 |
Aaron Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Hilz
COO | Chief Operating Officer | 66 | 13-07-24 |
David R. Wells
BRD | Director/Board Member | 61 | 22-12-27 |
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 5.64 | -4.08% | 60 603 |
24-05-20 | 5.88 | -15.64% | 165,778 |
24-05-17 | 6.97 | -38.37% | 348,902 |
24-05-16 | 11.31 | +25.81% | 411,195 |
24-05-15 | 8.99 | +13.65% | 74,210 |
Delayed Quote Nasdaq, May 21, 2024 at 01:18 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.02% | 3.86M | |
-13.86% | 2.88B | |
+1.74% | 188M | |
+13.04% | 50.96M |
- Stock Market
- Equities
- HSCS Stock